Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
Kidney Cancer Research Consortium
by Liz Hanson
1y ago
The post Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma appeared first on KCRC ..read more
Visit website
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease
Kidney Cancer Research Consortium
by Liz Hanson
1y ago
The post Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease appeared first on KCRC ..read more
Visit website
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study
Kidney Cancer Research Consortium
by Liz Hanson
1y ago
The post Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study appeared first on KCRC ..read more
Visit website
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
Kidney Cancer Research Consortium
by Liz Hanson
1y ago
The post Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma appeared first on KCRC ..read more
Visit website
Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma
Kidney Cancer Research Consortium
by Liz Hanson
1y ago
The post Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma appeared first on KCRC ..read more
Visit website
“PROBE”ing the Role of Cytoreductive Nephrectomy in Advanced Renal Cancer
Kidney Cancer Research Consortium
by Liz Hanson
1y ago
The post “PROBE”ing the Role of Cytoreductive Nephrectomy in Advanced Renal Cancer appeared first on KCRC ..read more
Visit website
Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma
Kidney Cancer Research Consortium
by Liz Hanson
1y ago
The post Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma appeared first on KCRC ..read more
Visit website
Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial
Kidney Cancer Research Consortium
by Liz Hanson
1y ago
The post Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial appeared first on KCRC ..read more
Visit website

Follow Kidney Cancer Research Consortium on FeedSpot

Continue with Google
Continue with Apple
OR